Advanced Filters
noise

Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,204 clinical trials
J Juliana zambrano, MD, MPH

A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With Depression

This is a pilot clinical trial to assess the feasibility, safety, and preliminary efficacy of ketamine-assisted group therapy for Spanish-speaking adults with depression

18 - 64 years of age All Phase 1/2
H Hiroaki Harashima

Focused Research On Neurofeedback Therapy In Eradicating Depression (FRONTIER)

This is an exploratory study to test the efficacy of a novel EEG neurofeedback method in depressed patients. The investigators will measure the change in depressive symptoms before and after the intervention of the novel EEG neurofeedback method using the Depression Rating Scale (primary endpoint). In addition, The investigators will …

18 years of age All Phase 1/2
Q Qianqian Xin

Improvement of Depression With Use of ATP

This clinical study is a randomized, double-blind, placebo-controlled trial with an intervention period of 4 weeks. Participants will be patients with moderate to severe depression who meet the inclusion criteria during the screening period. After recruitment written informed consent form will be signed and the baseline evaluation will be done …

18 - 65 years of age All Phase N/A
S Shantelena Mouzon

Assessment of Music Experiences in Navigating Depression Part 2

This study is again looking at the use of music and music therapy experiences in navigating depression. The researchers will provide 11 sessions of music therapy and half will be followed by recitals at the Third Street School Music Settlement where the kids enrolled in our study will observe and …

7 - 15 years of age All Phase N/A
Y Young Kim-wan, PhD

"Everyone is a Hope Builder" Project Study

The research aims to investigate the effectiveness of the therapeutic song-writing program on young people with depressive symptoms. This study adopts a multicentre randomized control trial two arms research design. A randomised controlled trial will compare a typical 7-session therapeutic song-writing program with a waitlist-control group to determine whether the …

13 - 24 years of age All Phase N/A
E Elina Santti, PhD

Dance-movement Therapy in the Treatment of Adolescent Depression

The aim of this research is to measure the effectiveness of Dance movement therapy in the treatment of adolescent depression.

13 - 17 years of age All Phase N/A
D Dennis Guevara

Pharmacologic Augmentation of TMS for Depression With D-serine

The goal of this study is to test whether combining D-serine with 30 treatments of a) iTBS and b) 18-Hz protocols will enhance clinical outcomes compared to rTMS with placebo (i.e., sugar pill). The investigators hypothesize that NMDA receptor activation via D-serine combined with repeated sessions of rTMS will produce …

18 - 80 years of age All Phase 1
M Mehmet Kemal Arıkan, Prof. Dr.

Neurobiological and Genomic Predictors of Relapse in Depression

The goal of this observational study is to test whether the discontinuation of antidepressant medications for patients with depression can be decided after the normalization of biological parameters. The main questions it aims are: When patients with depression treated with antidepressants, does their brain activity also become normal? If so, …

18 - 65 years of age All Phase N/A
S Shelley Cates

Researching Heat and Yoga for Mood Enhancement

This study will examine how doing heated yoga or non-heated yoga affects depression.

18 - 65 years of age All Phase N/A
M Mostafa M Bahaa, PhD

Dapagliflozin in Depression

Major depressive disorder (MDD) is currently one of the leading causes of disability and suicidal death worldwide, and despite extensive research and massive improvements in mental health, the nature of MDD remains ambiguous. Moreover, about two-thirds of MDD patients fail to optimally respond to currently available standard therapies, and many …

18 - 60 years of age All Phase 1/2

Simplify language using AI